• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Tootsie Roll Industries

Tootsie Roll Industries

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. American Hotel Income Properties REIT LP announces the acquisition of a new 110-room Oak Tree Inn hotel in Wellington, Kansas

    American Hotel Income Properties REIT LP announces the acquisition of a new 110-room Oak Tree Inn hotel in Wellington, Kansas

  2. Turkcell Iletisim Hizmetleri: Fourth Quarter and Full Year 2014 Results

    Turkcell Iletisim Hizmetleri: Fourth Quarter and Full Year 2014 Results

  3. Ultimate Stock-Pickers' Top 10 High-Conviction Purchases

    These top investment managers put new money to work in several wide-moat names, including United Technologies.

  4. Research and Markets: Europe Clothing B2C E-Commerce Market 2015

    Research and Markets: Europe Clothing B2C E-Commerce Market 2015

  5. ILS Technology, a Telit company, Enables the Information-Driven Enterprise with deviceWISE platform and Cloud Service for the Industrial Internet-of-Things

    ILS Technology, a Telit company, Enables the Information-Driven Enterprise with deviceWISE platform and Cloud Service for the Industrial Internet-of-Things

  6. Defne to Exhibit at Mobile World Congress 2015, booth 5G20, Mar 2 - 5, 2015, in Barcelona, ES

    Defne to Exhibit at Mobile World Congress 2015, booth 5G20, Mar 2 - 5, 2015, in Barcelona, ES

  7. TomTom reports fourth quarter and full year 2014 results

    TomTom reports fourth quarter and full year 2014 results

  8. Research and Markets: Eastern Europe Clothing B2C E-Commerce Market 2015

    Research and Markets: Eastern Europe Clothing B2C E-Commerce Market 2015

  9. Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder

    Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder

  10. Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder

    Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.